First published · Last updated
Recurrent Macular Edema Associated With Belzutifan Therapy for Metastatic Renal Cell Carcinoma
The journal article reports recurrent macular edema associated with belzutifan therapy for metastatic renal cell carcinoma. It was published by SAGE Publications on 2026-02-01.
Categories: public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 3/10
- Geographic reach
- 1/10
- Global importance
- 2/10
- Impact magnitude
- 2/10
- Positivity
- 2/10
- Urgency
- 3/10
Why it matters
The report documents a recurrent ocular adverse effect linked to a cancer therapy, which is directly relevant to clinicians and patients.

